NMPA mifepristone coverage for business development, investment, and market access teams
Earlier
Medium impact AnalysisMay 17, 2026
SCOTUS Restores Telehealth Access to Mifepristone: Implications for Pharma
SCOTUS · abortion · 3 min
Dr. Yuki TanakaHigh impact NewsMay 4, 2026
Mifepristone Access Continues Under Supreme Court Hold as Planned Parenthood Responds to 5th Circuit Ruling
Reproductive Health/Medical Abortion · 3 min
Dr. Priya SharmaPopular topics
- Drug Approvals 1,128 articles
- Clinical Trials 634 articles
- Regulatory Updates 687 articles
- Press Releases 443 articles
- Oncology 443 articles
- Mergers & Acquisitions 105 articles
- Rare Diseases 141 articles
Explore intelligence
- Global markets Cross-region command center
- Company directory Sponsor & marketer profiles
- Drug profiles INN & regulatory status
- Clinical trials hub Stage & therapy filters
- Pipeline programs R&D intelligence
- Patent landscape US & EP IP moats
- Event calendar Congress catalysts
- Regulatory reference Submission types & pathways